Year archive

RELIEF Therapeutics Holding AG — 2024 filings

All 42 regulatory filings released by RELIEF Therapeutics Holding AG (RLF) in 2024, sourced directly from the official regulator.

42 Filings

2024 Period

2024 filings (42)

Filing	Released	Lang
Relief Therapeutics Provides Update on Potential Transaction with Renexxion M&A Activity	2024-12-28	English
Relief Therapeutics Provides Update on Potential Transaction with Renexxion M&A Activity	2024-12-27	English
Relief Therapeutics Provides Update on Potential Transaction with Renexxion M&A Activity	2024-12-27	English
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial Regulatory Filings	2024-12-17	English
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial Legal Proceedings Report	2024-12-16	English
Relief Therapeutics Announces Final Readout of PKU GOLIKE Clinical Trial Earnings Release FY 2024	2024-12-16	English
Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations Regulatory Filings	2024-12-14	English
Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations Regulatory Filings	2024-12-13	English
Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations Regulatory Filings	2024-12-13	English
Relief Therapeutics Announces Positive Final Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa Regulatory Filings	2024-11-11	English
Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger M&A Activity	2024-11-04	English
Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE Regulatory Filings	2024-10-29	English
Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents Regulatory Filings	2024-10-25	English
Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment Regulatory Filings	2024-10-21	English
Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa Regulatory Filings	2024-10-08	English
Relief Therapeutics Reports Positive Results from RLF-OD032 Proof-of-Concept Clinical Study for Phenylketonuria Earnings Release Q4 2024	2024-10-04	English
Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement Regulatory Filings	2024-09-23	English
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 Investor Presentation	2024-09-18	English
Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 Regulatory Filings	2024-09-02	English
Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 Regulatory Filings	2024-09-02	English
Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update Earnings Release H1 2024	2024-08-30	English
Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update Earnings Release H1 2024	2024-08-30	English
Relief Therapeutics Secures up to $11 Million from Royalty Sales Capital/Financing Update	2024-08-05	English
Relief Therapeutics Secures up to $11 Million from Royalty Sales Regulatory Filings	2024-08-05	English
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting AGM Information	2024-06-27	English
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting AGM Information	2024-06-27	English
Relief Therapeutics Announces Executive Changes Board/Management Information	2024-06-03	English
Relief Therapeutics Announces Executive Changes Board/Management Information	2024-06-03	English
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders AGM Information	2024-05-30	English
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders AGM Information	2024-05-30	English
Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives Board/Management Information	2024-05-08	English
Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives Board/Management Information	2024-05-08	English
Relief Therapeutics has published its Annual Report Report Publication Announcement	2024-04-30	English
Relief Therapeutics has published its Annual Report Report Publication Announcement	2024-04-30	English
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting AGM Information	2024-04-26	English
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting Declaration of Voting Results & Voting Rights Announcements	2024-04-26	English
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting AGM Information	2024-03-27	English
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting AGM Information	2024-03-27	English
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE M&A Activity	2024-03-22	English
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE M&A Activity	2024-03-22	English
Relief Therapeutics Renews CHF 50 million Share Subscription Facility Capital/Financing Update	2024-02-28	English
Relief Therapeutics Renews CHF 50 million Share Subscription Facility Share Issue/Capital Change	2024-02-28	English